Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Edif A, 2do Piso, Ciudad Universitaria, CP 04510, Ciudad de México, Mexico.
Exp Parasitol. 2011 Jan;127(1):294-9. doi: 10.1016/j.exppara.2010.06.025. Epub 2010 Jul 3.
Using a murine model of cysticercosis caused by the Taenia crassiceps ORF strain, we developed a fluorescent quantitative evaluation of the action of two well known anti-helminthic drugs: albendazole sulfoxide and praziquantel. The fluorescence emitted by a biotransformed CellTracker Probe known as CellTracker Green CMFDA in the vesicular fluids of cysticerci was estimated, and the results were compared with macroscopic observations of the parasites. The pharmacological EC(50) value of each drug and changes in the level of biotransformation of the fluorescent tracker caused by the drugs could be easily calculated. These drug-induced changes in biotransformation could be related to changes in the GSH/GSSG ratio of parasites. Both the cysticercosis murine model and the CMFDA biotransformation assay could be used as an in vitro screening method to evaluate potential or well known cysticidal drugs.
利用由猪囊尾蚴 ORF 株引起的囊尾蚴病的小鼠模型,我们开发了一种荧光定量评估两种著名抗蠕虫药物:阿苯达唑亚砜和吡喹酮作用的方法。估计囊尾蚴囊泡液中称为 CellTracker Green CMFDA 的生物转化 CellTracker Probe 发出的荧光,并将结果与寄生虫的宏观观察进行比较。可以轻松计算每种药物的药理 EC(50)值以及药物引起的荧光示踪剂生物转化水平的变化。这些药物引起的生物转化变化可能与寄生虫的 GSH/GSSG 比值变化有关。囊尾蚴病小鼠模型和 CMFDA 生物转化测定均可作为体外筛选方法,以评估潜在或已知的杀囊尾蚴药物。